Tuesday, September 26, 2023

561.316.3330

Biotechnology News Magazine

New from Jackson ImmunoResearch Anti-Human IgE Antibodies

Antibodies for Serology and Diagnostics

Latest Posts

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Airway Therapeutics began recruiting patients on March 28, 2023, for daily treatment up to 7 days at the highest dose of zelpultide alfa (rhSP-D) following a Data Safety Monitoring Committee (DSMC) report of no safety concerns.

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians access to medical algorithms generating insights to help improve care decisions.

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

PathO3Gen Solutions’ multi-patented UVZone Shoe Sanitizing Stations, when placed in high-traffic and high-risk areas, enhance healthcare facility infection control measures, and may improve overall hospital biosafety.

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® triggers a $10 million milestone payment by Pharming to Novartis.

Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets.

JIR Mouse Monoclonal Anti-Human IgE antibodies are the latest addition to our suite of products suitable for diagnostics research and development. Specific for Human IgE antibodies, they complement our existing Anti-Human IgG, IgM, and IgA antibodies. Anti-Human IgE is available conjugated to a select range of reporter molecules, including Alkaline Phosphatase and Biotin enabling excellent sensitivity for immunoassay applications.

Jackson ImmunoResearch Anti-Human IgE is a mouse-derived monoclonal antibody with reactivity to human E class immunoglobulins and is epsilon (ε) chain specific and has been tested by ELISA and shows minimal cross-reactivity to other classes of human immunoglobulin (IgG, IgM, or IgA).

JIR Mouse Anti-Human IgE is available conjugated to a range of reporter molecules and is suitable to detect human IgE by a variety of techniques, including ELISA (Enzyme-linked Immunosorbent Assay), Lateral Flow Immunoassay (LFIA), Flow cytometry, Western blot, and CLIA (Chemiluminescent Immunoassay).

Matthew Smith, Commercial Director, commented, “We are excited to launch Jackson ImmunoResearch Anti-Human IgE antibodies as part of our existing suite of reagents suitable for developing high-quality human serology and diagnostic tests. They will allow scientists to harness the sensitivity and specificity of JIR antibodies in a wider range of fields such as allergy.”

These antibodies are available for purchase now, directly from Jackson ImmunoResearch in the USA and Europe or through official distribution partners worldwide. More information on JIR Mouse Monoclonal Anti-Human IgE antibodies is available at www.jacksonimmuno.com/ige

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine